0
Skip to Content
Inside China Biotech
Home
How to Enter China
PCV Insights
Deals & Investment
Podcast
Inside China Biotech
Home
How to Enter China
PCV Insights
Deals & Investment
Podcast
Home
How to Enter China
PCV Insights
Deals & Investment
Podcast
Yihang Chen 11/21/26 Yihang Chen 11/21/26

Globalization vs Deglobalization

Read More
Yihang Chen 11/8/26 Yihang Chen 11/8/26

China's Biotech Licensing Boom Is Reaching the Income Statement. Is That Sustainable?

Read More
Yihang Chen 10/24/26 Yihang Chen 10/24/26

China's Biotech Financing Was Already Changing. What Will COINS Add?

Read More
Yihang Chen 8/9/26 Yihang Chen 8/9/26

BINSA and the WuXi AppTec Case: Two Distinct Tracks in U.S. Biotech National Security Policy

Read More
Yihang Chen 7/26/26 Yihang Chen 7/26/26

From Aiolos to Kailera: Who Captures the Value in a China-to-Global NewCo?

Read More
Yihang Chen 6/16/26 Yihang Chen 6/16/26

Clinical Going Global: Why Australia and Europe Matter More for Chinese Biotech

Read More
Yihang Chen 5/5/25 Yihang Chen 5/5/25

Candid Therapeutics and UCB: When China-Origin Assets Become Global Strategy

Read More